Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1038133/000103813322000031/hska-20220630.htm
SEC Filings
HSKA Annual Reports
10-K Annual Report February 2023
10-K Annual Report February 2022
10-K Annual Report February 2021
10-K Annual Report February 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report March 2015
10-K Annual Report March 2014
10-K Annual Report February 2023
10-K Annual Report February 2022
10-K Annual Report February 2021
10-K Annual Report February 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report March 2015
10-K Annual Report March 2014
HSKA Quarterly Reports
HSKA Corporate News
Financial Exhibit
Financial Obligation Increase
New Agreement June 2023
Bylaw Change
Change in Assets
Change in Control
Event for Officers
Financial Exhibit
Listing Status
Other Events
Security Holders Change June 2023
Vote of Security Holders June 2023
Other Events June 2023
Other Events May 2023
Earnings Release
Financial Exhibit May 2023
Event for Officers
Vote of Security Holders May 2023
Financial Exhibit
New Agreement
Other Events April 2023
Earnings Release
Financial Exhibit February 2023
Event for Officers February 2023
Financial Exhibit
Financial Obligation Increase
New Agreement
Financial Obligation Increase
New Agreement
June 2023
Bylaw Change
Change in Assets
Change in Control
Event for Officers
Financial Exhibit
Listing Status
Other Events
Security Holders Change
Change in Assets
Change in Control
Event for Officers
Financial Exhibit
Listing Status
Other Events
Security Holders Change
June 2023
Vote of Security Holders
June 2023
Other Events
June 2023
Other Events
May 2023
Earnings Release
Financial Exhibit
Financial Exhibit
May 2023
Event for Officers
Vote of Security Holders
Vote of Security Holders
May 2023
Financial Exhibit
New Agreement
Other Events
New Agreement
Other Events
April 2023
Earnings Release
Financial Exhibit
Financial Exhibit
February 2023
Event for Officers
February 2023
Last10K.com | 10-Q Quarterly Report Mon Aug 08 2022
Exhibit 99.1
Heska Corporation |  | ||||||||||
| Jon Aagaard | |||||||||||
| Investor Relations | |||||||||||
| 970.619.3033 | |||||||||||
| investorrelations@heska.com | |||||||||||
Heska Corporation Reports Second Quarter 2022 Results
LOVELAND, CO, August 8, 2022 -- Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments (North America and International) for its second quarter ended June 30, 2022. In this release, Point of Care is “POC”, Pharmaceuticals, Vaccines and Diagnostics is “PVD”, Other Vaccines and Pharmaceuticals is “OVP”, and basis points is “bps”.
Second Quarter 2022 and Year Over Year ("YOY") Metrics
$ in millions except Earnings Per Share ("EPS")
| Q2 ($) | Q2 (%) YOY | |||||||
| Consolidated Revenue | $64.7 | (0.4)% | ||||||
| North America Revenue | $40.9 | 0.9% | ||||||
| International Revenue | $23.8 | (2.5)% | ||||||
| Q2 (%) | Q2 YOY bps | |||||||
| Consolidated Gross Margin | 42.3% | 30 | ||||||
Net Margin1 | (7.6)% | (730) | ||||||
Adjusted EBITDA Margin1,2 | 10.8% | (220) | ||||||
| Q2 ($) | Q2 (%) YOY | |||||||
| Net loss attributable to Heska | $(5.2) | NM3 | ||||||
| Net loss | $(4.9) | NM3 | ||||||
Adjusted EBITDA2 | $7.0 | (17.2)% | ||||||
| EPS, Diluted | $(0.51) | NM3 | ||||||
Non-GAAP EPS, Diluted2 | $0.34 | (32.0)% | ||||||
1Net margin and adjusted EBITDA margin represents the ratio of net (loss) income and adjusted EBITDA, respectively, to revenue. 2See “Use of Non-GAAP Financial Measures” and related reconciliations provided below.3"NM" is not meaningful.
Report Highlights
•Quarterly revenue increased 4.0% on a constant currency basis to $64.7 million, led by North America Lab Consumables growth of 5.4% and sales in VetZ software solutions.
•Year over year gross margin: Consolidated up 30 bps to 42.3%, International up 370 bps to 35.9%, and North America down approximately 200 bps to 46.0%.
The following information was filed by Heska Corp (HSKA) on Monday, August 8, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Heska Corp's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Heska Corp.
Assess how Heska Corp's management team is paid from their Annual Proxy
Heska Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Rating
Learn More
Filter Sentiment:
Filter Category:
Filter Subcategory:
-
Financial - Earnings Highlight
The increase in gross profit and gross margin for both periods is driven by favorable product mix, particularly within POC laboratory consumables.
-
Financial - Earnings Highlight
Management uses EBITDA, adjusted EBITDA, adjusted EBITDA margin and non-GAAP net income (loss) per diluted share as key profitability measures, which are included in monthly or quarterly analyses of our operating results to our senior management team, our annual budget and related goal setting and other performance measurements.
-
Financial - Earnings Highlight
The increases in both gross profit and gross margin percentage were due to higher sales of consumables relative to total sales, which are our highest margin products, further strengthened by product rationalization and transition effort within our international segment and overall annual price increases.
-
Financial - Income Highlight
Net (Loss) Income Attributable to Heska Corporation Net loss attributable to Heska was $5.2 million in the three months ended June 30, 2022, compared to net loss attributable to Heska of $0.6 million in the three months ended June 30, 2021.
-
Revenue - Product Highlight
Such statements, which include statements concerning future revenue sources and concentration, international market expansion, gross profit margins, selling and marketing expenses, remaining minimum performance obligations, research and development expenses, general and administrative expenses, capital resources, financings or borrowings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed under the caption "Risk Factors" contained in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 that could cause actual results to differ materially from those projected.
-
Financial - Expense
The change for the six...Read more
-
Other - Other
-44- Liquidity, Capital Resources and...Read more
-
Revenue - Geography
Effect of currency translation on...Read more
-
Financial - Earnings
Gross margin increased to 42.3%...Read more
-
Financial - Earnings
Gross margin increased to 43.6%...Read more
-
Financial - Income
(4) Represents income tax expense...Read more
-
Other - Other
Our financial position remains strong...Read more
-
Other - Other
The non-GAAP financial measures presented...Read more
-
M & A - Other
The acquisition of VetZ also...Read more
-
Revenue - Geography
The decrease is driven by...Read more
-
Financial - Expense
Operating Expenses Selling and marketing...Read more
-
Other - Other
The $0.5 million increase was...Read more
-
Revenue - Product
The increase for the six...Read more
-
M & A - Other
The acquisition of VetZ also...Read more
-
Financial - Expense
The Company recognized $0.1 million...Read more
-
Financial - Expense
The metrics were unfavorably impacted...Read more
-
Other - Other
Our belief may prove to...Read more
-
Revenue - Product
Since items in this area...Read more
-
Revenue - Geography
North America Segment -42- North...Read more
-
Revenue - Geography
North America segment revenue increased...Read more
-
Revenue - Product
Total revenue increased 3.2% to...Read more
-
Financial - Income
Income Tax Benefit For the...Read more
-
Revenue - Product
Our experience has been that...Read more
-
Financial - Earnings
Gross Profit Gross profit increased...Read more
-
Financial - Earnings
Gross profit increased 7.1% to...Read more
-
Financial - Income
In the three months ended...Read more
-
Financial - Income
For the six months ended...Read more
-
Financial - Income
In the six months ended...Read more
-
Financial - Expense
-37- General and administrative expenses...Read more
-
Financial - Expense
General and administrative expenses increased...Read more
-
Revenue - Product
For the three months ended...Read more
-
Financial - Earnings
Net loss attributable to Heska...Read more
-
Other - Other
The increase for the six...Read more
-
Revenue - Product
This is mostly offset by...Read more
-
Financial - Expense
This incorporates the discrete tax...Read more
-
Financial - Income
See "Non-GAAP Financial Measures" for...Read more
-
Revenue - Product
The decreased operating loss for...Read more
-
Other - Other
We believe these non-GAAP measures...Read more
-
Financial - Expense
Research and development expenses increased...Read more
-
Financial - Expense
Research and development expenses increased...Read more
-
Other - Other
The tax benefit for the...Read more
-
Financial - Expense
The loss in the current...Read more
-
Financial - Expense
We view this facility as...Read more
-
Other - Other
For example, we actively seek...Read more
-
Other - Other
We will continue to actively...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Cover Page
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of (Loss) Income
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Loss
Condensed Consolidated Statements Of Stockholders' Equity
Accrued Liabilities
Accrued Liabilities (Details)
Accrued Liabilities (Tables)
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) (Details)
Accumulated Other Comprehensive Income (Loss) (Tables)
Acquisition And Related Party Items
Acquisition And Related Party Items (Tables)
Acquisition And Related Party Items - Additional Information (Details)
Acquisition And Related Party Items - Intangible Assets Acquired, Amortization Method (Details)
Acquisition And Related Party Items - Preliminary Purchase Price Acquisition (Details)
Acquisition And Related Party Items - Unaudited Pro Forma Financial Information (Details)
Capital Stock
Capital Stock (Tables)
Capital Stock - Stock Options And Restricted Stock (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Convertible Notes And Credit Facility
Convertible Notes And Credit Facility (Tables)
Convertible Notes And Credit Facility - Carrying Amount Of Debt (Details)
Convertible Notes And Credit Facility - Convertible Notes Narrative (Details)
Convertible Notes And Credit Facility - Interest Expense (Details)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Goodwill And Other Intangibles
Goodwill And Other Intangibles (Details)
Goodwill And Other Intangibles (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Interest And Other (Income) Expense, Net
Interest And Other (Income) Expense, Net (Details)
Interest And Other (Income) Expense, Net (Tables)
Inventories, Net
Inventories, Net (Details)
Inventories, Net (Tables)
Investments In Unconsolidated Affiliates
Investments In Unconsolidated Affiliates (Details)
Investments In Unconsolidated Affiliates (Tables)
Leases
Leases (Tables)
Leases - Operating And Financing Lease Balances (Details)
Leases - Sales-Type Leases And Lease Income (Details)
Note Receivables
Note Receivables (Tables)
Note Receivables - Additional Information (Details)
Note Receivables - Schedule (Details)
Operations And Summary Of Significant Accounting Policies
Operations And Summary Of Significant Accounting Policies (Policies)
Operations And Summary Of Significant Accounting Policies (Tables)
Operations And Summary Of Significant Accounting Policies - Fair Value (Details)
Operations And Summary Of Significant Accounting Policies - Fair Value Roll Forward (Details)
Operations And Summary Of Significant Accounting Policies - Narrative (Details)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Revenue
Revenue (Tables)
Revenue - Disaggregation (Details)
Revenue - Performance Obligations (Details)
Segment Reporting
Segment Reporting (Details)
Segment Reporting (Tables)
Material Contracts, Statements, Certifications & more
Heska Corp provided additional information to their SEC Filing as exhibits
Ticker: HSKA
CIK: 1038133
Form Type: 10-Q Quarterly Report
Accession Number: 0001038133-22-000031
Submitted to the SEC: Mon Aug 08 2022 12:09:07 PM EST
Accepted by the SEC: Mon Aug 08 2022
Period: Thursday, June 30, 2022
Industry: Biological Products No Disgnostic Substances
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/hska/0001038133-22-000031.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...